Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SR1664

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Peroxisome proliferator-activated receptors (PPARs) are pharmacological targets for the treatment of metabolic disorders… Expand
Is this relevant?
2017
2017
The nuclear receptor PPARγ regulates adipogenesis and plays a central role in lipid and glucose homeostasis, and is the molecular… Expand
Is this relevant?
2017
2017
Thiazolidinediones (TZD) function as potent anti-diabetic drugs through their direct action on the nuclear receptor peroxisome… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
We revealed the X-ray structure of PPARγ co-crystallized with SR1664 bound to the alternate binding site of PPARγ and confirmed… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
The peroxisome proliferator-activated receptor γ (PPARγ) ligands are important therapeutic drugs for the treatment of type 2… Expand
  • figure 1
  • figure 3
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) is the master regulator of adipogenesis and the… Expand
Is this relevant?
2015
2015
Peroxisome proliferator-activated receptor γ (PPARγ) is a member of the nuclear receptor family and plays key roles in glucose… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
Background: PPARγ ligands can be used in numerous metabolic syndromes. Results: A novel non-agonist PPARγ ligand, UHC1 exhibited… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PPARγ is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs including rosiglitazone and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Thiazolidinediones (TZDs), which are agonists of the nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ), are… Expand
Is this relevant?